A Review Article on AI in Personalized Medicine & Novel Pharamacology

A revolutionary change in contemporary healthcare is represented by the incorporation of artificial intelligence (AI) into personalized treatment. Utilizing a patient's genetic, molecular, and clinical characteristics, personalized medicine customizes treatments and diagnostics to maximize benefits and reduce side effects. By making it possible to analyse complicated datasets, such as those from genomes, proteomics, medical imaging, and electronic health records, AI technologies improve this paradigm by identifying biomarkers, forecasting treatment outcomes, and directing precision drug delivery. The creation of predictive, preventive, individualized, and participative healthcare models is encouraged by this synergy. At the same time, new developments in pharmacology keep redefining treatment strategies for a variety of illnesses. Drug development innovations for diseases like Parkinson's disease, anxiety, cardiovascular disease, cystic fibrosis, gastrointestinal problems, and urinary tract infections concentrate on focusing on certain neurotransmitter systems and molecular pathways.

Artificial intelligence (AI)in healthcare, Personalized medicine

1. Karalis VD. The Integration of Artificial Intelligence into Clinical Practice. Applied Biosciences. 2024; 3:14–44. [Google Scholar] [Crossref]

2. Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Meulis K, and Rhee K. Precision medicine, AI, and the future of personalized health care. Clin Trans Sci. 2021;14(1):86-93. Cross Ref [Google Scholar] [Crossref]

3. Shah HH, Lodhi SK. AI in Personalized Medicine: Tailoring Treatment Plans Based on Individual Patient Data. Global Trends in Science and Technology. 2025 Jan 24;1(1):15-2 [Google Scholar] [Crossref]

4. Odenike, O.; Thirman, M.J.; Artz, A.S.; Godley, L.A.; Larson, R.A.; Stock, W. Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia; are we there yet? Semin. Oncol. 2011, 38, 196–214. [Google Scholar] [CrossRef] [Google Scholar] [Crossref]

5. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA and Bradley L: The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 9:665–674. 2007. View Article: Google Scholar: PubMed/NCBI [Google Scholar] [Crossref]

6. Schroth, W.; Goetz, M.P.; Hamann, U.; Fasching, P.A.; Schmidt, M.; Winter, S.; Fritz, P.; Simon, W.; Suman, V.J.; Ames, M.M.; Safron, S.L.; Kuffel, M.J.; Ulmer, H.U.; Boländer, J.; Strick, R.; Beckmann, M.W.; Koelbl, H; westbound, R.M.; Ingle, J.N.; Eichelbaum, M.; Schwab, M.; Brauch, H. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 2009, 302, 1429–1436. [Google Scholar] [Cross ref] [Google Scholar] [Crossref]

7. Parekh AD, Shaikh OA, Simran F, Manan S. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history: short communication. Ann Med Sorg (Lond). 2023; 85:5831–3. [Google Scholar] [Crossref]

8. Kawale T, Bandagi S, Dane B, Jamdade K. Pharmacological innovations in the treatment of gastrointestinal disorders: a comprehensive review. International Journal of Scientific Research and Technology. 2024 Sep 27. Hamburg MA, Collins FS. The path to personalized medicine. New England Journal of Medicine. 2010 Jul 22;363(4):301-4. [Google Scholar] [Crossref]

9. Parekh AD, Shaikh OA, Simran F, Manan S. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history: short communication. Ann Med Surg (Lond). 2023;85: 5831–3. [Google Scholar] [Crossref]

10. Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Human Computer. 2023;14: 8459–86. [Google Scholar] [Crossref]

11. Hu Y, Wen G, Liao H, et al. Automatic Construction of Chinese Herbal Prescriptions from Tongue Images Using CNNs and Auxiliary Latent Therapy Topics. IEEE Trans Cybern. 2021;51(2):708–721. [Google Scholar] [Crossref]

12. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2005 Nov;19(6):567-96. [Google Scholar] [Crossref]

13. Hanrahan JW, Sampson HM, Thomas DY. Novel pharmacological strategies to treat cystic fibrosis. Trends in pharmacological sciences. 2013 Feb 1;34(2):119-25. [Google Scholar] [Crossref]

14. Blasiak A, Khong J, Kee T. CURATE. AI: optimizing personalized medicine with artificial intelligence. SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2020 Apr;25(2):95-105. [Google Scholar] [Crossref]

15. Schork NJ, Nazor K (2017) Integrated genomic medicine: a paradigm for rare diseases and beyond. Adv Genet 97:81–113 [Google Scholar] [Crossref]

16. Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Human Computer. 2023;14: 8459–86. [Google Scholar] [Crossref]

17. Parekh AD, Shaikh OA, Simran F, Manan S. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history: short communication. Ann Med Surg (Lond). 2023;85: 5831–3. [Google Scholar] [Crossref]

18. Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Meulis K, and Rhee K. Precision medicine, AI, and the future of personalized health care. Clin Trans Sci. 2021;14(1):86-93. Cross Ref [Google Scholar] [Crossref]

19. Parekh AD, Shaikh OA, Simran F, Manan S. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history: short communication. Ann Med Sorg (Lond). 2023; 85:5831–3. [Google Scholar] [Crossref]

20. Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, Ramirez BI, Sánchez-Guirales SA, Simon JA, Tomietto G, Rapti C. Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine. Pharmaceutics. 2024 Oct 14;16(10):1328. [Google Scholar] [Crossref]

21. Cè M, Irmici G, Foschini C, Danesini GM, Falsitta LV, Serio ML, Fontana A, Martinenghi C, Oliva G, Cellina M. Artificial intelligence in brain tumor imaging: a step toward personalized medicine. Current Oncology. 2023 Feb 22;30(3):2673-701. [Google Scholar] [Crossref]

22. Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Human Computer. 2023;14: 8459–86. [Google Scholar] [Crossref]

23. Blasiak A, Khong J, Kee T. CURATE. AI: optimizing personalized medicine with artificial intelligence. SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2020 Apr;25(2):95-105. [Google Scholar] [Crossref]

24. Schork NJ, Nazor K (2017) Integrated genomic medicine: a paradigm for rare diseases and beyond. Adv Genet 97:81–113 [Google Scholar] [Crossref]

25. Parekh AD, Shaikh OA, Simran F, Manan S. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history: short communication. Ann Med Surg (Lond). 2023;85: 5831–3. [Google Scholar] [Crossref]

26. Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Human Computer. 2023;14: 8459–86. [Google Scholar] [Crossref]

27. Parekh AD, Shaikh OA, Simran F, Manan S. Artificial intelligence (AI) in personalized medicine: AI-generated personalized therapy regimens based on genetic and medical history: short communication. Ann Med Surg (Lond). 2023;85: 5831–3. [Google Scholar] [Crossref]

28. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2005 Nov;19(6):567-96. [Google Scholar] [Crossref]

29. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2005 Nov;19(6):567-96. [Google Scholar] [Crossref]

30. Schork NJ, Nazor K (2017) Integrated genomic medicine: a paradigm for rare diseases and beyond. Adv Genet 97:81–113. [Google Scholar] [Crossref]

31. Lewis J, Lopez M, Ramachandran H. The Role of Artificial Intelligence in Revolutionizing Industries: Opportunities, Challenges, and Ethical Considerations. AlgoVista: Journal of AI and Computer Science.;2(2):23-31. [Google Scholar] [Crossref]

32. Hu Y, Wen G, Liao H, et al. Automatic Construction of Chinese Herbal Prescriptions from Tongue Images Using CNNs and Auxiliary Latent Therapy Topics. IEEE Trans Cybern. 2021;51(2):708–721. [Google Scholar] [Crossref]

33. Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, Ramirez BI, Sánchez-Guirales SA, Simon JA, Tomietto G, Rapti C. Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine. Pharmaceutics. 2024 Oct 14;16(10):1328. [Google Scholar] [Crossref]

34. Bonuccelli U, Del Dotto P. New pharmacologic horizons in the treatment of Parkinson disease. Neurology. 2006 Oct 10;67(7_suppl_2): S30-8. [Google Scholar] [Crossref]

35. Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA. Novel approaches for the treatment of Alzheimer’s and Parkinson’s disease. International journal of molecular sciences. 2019 Feb 8;20(3):719. [Google Scholar] [Crossref]

36. Gifari MW, Samodro P, Kurniawan DW. Artificial intelligence toward personalized medicine. Pharmaceut. Sci. Res. 2021;8(2):1. [Google Scholar] [Crossref]

37. Hanrahan JW, Sampson HM, Thomas DY. Novel pharmacological strategies to treat cystic fibrosis. Trends in pharmacological sciences. 2013 Feb 1;34(2):119-25. [Google Scholar] [Crossref]

38. Zeitlin PL. Novel pharmacologic therapies for cystic fibrosis. The Journal of clinical investigation. 1999 Feb 15;103(4):447-52. [Google Scholar] [Crossref]

39. Kawale T, Bandagi S, Dane B, Jamdade K. Pharmacological innovations in the treatment of gastrointestinal disorders: a comprehensive review. International Journal of Scientific Research and Technology. 2024 Sep 27. Hamburg MA, Collins FS. The path to personalized medicine. New England Journal of Medicine. 2010 Jul 22;363(4):301-4. [Google Scholar] [Crossref]

40. Schapira AH, Bezard E, Brotchie J, Calon F, Colling ridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Novère NL, Obeso JA. Novel pharmacological targets for the treatment of Parkinson's disease. Nature reviews Drug discovery. 2006 Oct 1;5(10):845-54 [Google Scholar] [Crossref]

• Artificial Intelligence in Pharmacology, Drug Safety and Toxicity
• Seroprevalence and Associated Risk Factors of Treponema Pallidum Infection among Pregnant Women Attending Antenatal Clinics in Lokoja, Kogi State
• In Silico Evaluation of Hyptis Verticillata-Derived Phytochemicals Targeting Estrogen Receptor Alpha (Erα) and Progesterone Receptor in Hormone-Dependent Breast Cancer